| First Author | Haybaeck J | Year | 2009 |
| Journal | Cancer Cell | Volume | 16 |
| Issue | 4 | Pages | 295-308 |
| PubMed ID | 19800575 | Mgi Jnum | J:153708 |
| Mgi Id | MGI:4366130 | Doi | 10.1016/j.ccr.2009.08.021 |
| Citation | Haybaeck J, et al. (2009) A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16(4):295-308 |
| abstractText | Hepatitis B and C viruses (HBV and HCV) cause chronic hepatitis and hepatocellular carcinoma (HCC) by poorly understood mechanisms. We show that cytokines lymphotoxin (LT) alpha and beta and their receptor (LTbetaR) are upregulated in HBV- or HCV-induced hepatitis and HCC. Liver-specific LTalphabeta expression in mice induces liver inflammation and HCC, causally linking hepatic LT overexpression to hepatitis and HCC. Development of HCC, composed in part of A6(+) oval cells, depends on lymphocytes and IKappa B kinase beta expressed by hepatocytes but is independent of TNFR1. In vivo LTbetaR stimulation implicates hepatocytes as the major LT-responsive liver cells, and LTbetaR inhibition in LTalphabeta-transgenic mice with hepatitis suppresses HCC formation. Thus, sustained LT signaling represents a pathway involved in hepatitis-induced HCC. |
